학술논문

Different types of diabetes mellitus and risk of thyroid cancer: A meta-analysis of cohort studies.
Document Type
Report
Author
Dong WW; Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, China.; Zhang DL; Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, China.; Wang ZH; Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, China.; Lv CZ; Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, China.; Zhang P; Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, China.; Zhang H; Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, China.
Source
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE
Subject
Language
English
ISSN
1664-2392
Abstract
Objective: Sex-specific thyroid cancer risk exists in patients diagnosed with diabetes mellitus (DM). However, thyroid cancer risk in different types of DM is still unclear. This meta-analysis aims to identify the real correlation between different types of DM and thyroid cancer risk in both sexes.
Methods: Studies were identified by an electronic search of PubMed, EMBASE, and Cochrane Library on 16 January 2022. A random-effects model was used to estimate the relative risks (RRs). The Cochran's Q and I 2 statistics were computed to detect heterogeneity between studies.
Results: In comparison with non-DM counterparts, patients with DM had a 1.32-fold higher risk of thyroid cancer (95% CI, 1.22-1.44) with 1.26-fold (95% CI, 1.12-1.41) in men and 1.36-fold (95% CI, 1.22-1.52) in women, respectively. Subgroup analysis by the type of DM showed that the RR of thyroid cancer in patients with type 2 diabetes was 1.34 (95% CI, 1.17-1.53) in the study population with 1.32 (95% CI, 1.12-1.54) in men and 1.37 (95% CI, 1.12-1.68) in women, respectively; the RR of thyroid cancer was 1.30 (95% CI, 1.17-1.43) in patients with gestational diabetes; the risk of thyroid cancer in patients with type 1 diabetes was 1.51-fold in women but not in men. Although there were some heterogeneities, it did not affect the above results of this study.
Conclusion: This study indicates that, compared with non-DM individuals, patients with any type of DM have an elevated thyroid cancer risk. This positive correlation between type 2 diabetes and thyroid cancer risk exists in both men and women.
Systematic Review Registration: https://www.crd.york.ac.uk/prospero/, CRD42022304028.
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
(Copyright © 2022 Dong, Zhang, Wang, Lv, Zhang and Zhang.)